What is it about?
An observational study comparing pts at ICU receiving polyB in combination with another antibiotic (resistant in vitro) and polyB as the single agent.
Featured Image
Why is it important?
We showed that there was a significant improvemnt in 30-d mortality in patients who received polyB in combination.
Perspectives
Read the Original
This page is a summary of: Polymyxin B in Combination with Antimicrobials LackingIn VitroActivity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections, Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals,
DOI: 10.1128/aac.00494-15.
You can read the full text:
Contributors
The following have contributed to this page